Skip to main content

Advertisement

SpringerLink
Log in

Have Traditional Heart Failure Management Programs Reached Their “Use by” Date? Time to Apply More Nuanced Care

  • Implementation (L E Rohde, Section Editor)
  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To determine the current evidence supporting the otherwise proven heart failure management programs (HFMPs) in the setting of an increasingly older and more complex patient population.

Recent Findings

Attempts to replace proven face-to-face, multidisciplinary management of HF with remote management techniques (including telemedicine and implantable remote monitoring devices) have yielded mixed results. This may well reflect the clinical cascade effect of greater surveillance paradoxically leading to worse health outcomes as well as a narrow focus on HF alone in patients with clinically significant multimorbidity. Concurrently, there is preliminary evidence that the increasing phenomenon of HF and multimorbidity in older patients is undermining the otherwise positive impact of “traditional” HFMPs.

Summary

A more nuanced approach to determining who would benefit from what form of HF management, including the integration of remote surveillance techniques, is required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Stewart S, MacIntyre K, Capewell S, McMurray J. Heart failure and the aging population: an increasing burden in the 21st century? Heart. 2003;89(1):49–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e146–603.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shafie AA, Tan YP, Ng CH. Systematic review of economic burden of heart failure. Heart Fail Rev. 2018;23(1):131–45.

    Article  CAS  PubMed  Google Scholar 

  5. Stewart S, Riegel B, Boyd C, Ahamed Y, Thompson DR, Burrell LM, et al. Establishing a pragmatic framework to optimise health outcomes in heart failure and multimorbidity (ARISE-HF): a multidisciplinary position statement. Int J Cardiol. 2016;212:1–10.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chen L, Chan YK, Busija L, Norekval TM, Riegel B, Stewart S. Malignant and benign phenotypes of multimorbidity in heart failure: implications for clinical practice. J Cardiovasc Nurs. 2018:1.

  7. Tisminetzky M, Gurwitz JH, Fan D, Reynolds K, Smith DH, Magid DJ, et al. Multimorbidity burden and adverse outcomes in a community-based cohort of adults with heart failure. J Am Geriatr Soc. 2018;66(12):2305–13.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Fitch K, Lau J, Engel T, Medicis JJ, Mohr JF, Weintraub WS. The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings. Clinicoecon Outcomes Res. 2018;10:855–63.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Storrow AB, Jenkins CA, Self WH, Alexander PT, Barrett TW, Han JH, et al. The burden of acute heart failure on U.S. emergency departments. JACC Heart Fail. 2014;2(3):269–77.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ponikowski P, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed). 2016;69(12):1167.

    Article  Google Scholar 

  11. McAlister FA, et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44(4):810–9.

    PubMed  Google Scholar 

  12. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333(18):1190–5.

    Article  CAS  PubMed  Google Scholar 

  13. Stewart S, Marley JE, Horowitz JD. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet. 1999;354(9184):1077–83.

    Article  CAS  PubMed  Google Scholar 

  14. Blue L, Lang E, McMurray JJV, Davie AP, McDonagh TA, Murdoch DR, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ. 2001;323(7315):715–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Inglis SC, Clark RA, McAlister F, Stewart S, Cleland JG. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane review. Eur J Heart Fail. 2011;13(9):1028–40.

    Article  PubMed  Google Scholar 

  16. McDonald K, Troughton R, Dahlström U, Dargie H, Krum H, van der Meer P, et al. Daily home BNP monitoring in heart failure for prediction of impending clinical deterioration: results from the HOME HF study. Eur J Heart Fail. 2018;20(3):474–80.

    Article  CAS  PubMed  Google Scholar 

  17. Dierckx R, Inglis SC, Clark RA, Prieto-Merino D, Cleland JGF. Telemedicine in heart failure: new insights from the Cochrane meta-analyses. Eur J Heart Fail. 2017;19(3):304–6.

    Article  PubMed  Google Scholar 

  18. Chaudhry SI, Barton B, Mattera J, Spertus J, Krumholz HM. Randomized trial of telemonitoring to improve heart failure outcomes (Tele-HF): study design. J Card Fail. 2007;13(9):709–14.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, et al. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail. 2010;12(12):1354–62.

    Article  PubMed  Google Scholar 

  20. Boyne JJ, di van Asselt A, Gorgels APM, Steuten LMG, de Weerd G, Kragten J, et al. Cost-effectiveness analysis of telemonitoring versus usual care in patients with heart failure: the TEHAF-study. J Telemed Telecare. 2013;19(5):242–8.

    Article  PubMed  Google Scholar 

  21. Tse G, Chan C, Gong M, Meng L, Zhang J, Su XL, et al. Telemonitoring and hemodynamic monitoring to reduce hospitalization rates in heart failure: a systematic review and meta-analysis of randomized controlled trials and real-world studies. J Geriatr Cardiol. 2018;15(4):298–309.

    PubMed  PubMed Central  Google Scholar 

  22. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–9.

    Article  PubMed  Google Scholar 

  23. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, et al. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation. 2010;121(9):1086–95.

    Article  PubMed  Google Scholar 

  24. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658–66.

    Article  PubMed  Google Scholar 

  25. • Feldman T, et al. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018;137(4):364–75. This phase II randomised trial of a transcatheter interatrial shunt device implanted in 22 of 44 patients with heart failure with preserved ejection fraction is representative of a new generation of more invasive devices (often with monitoring capacity) to directly improve cardiac function. The challenge for all these devices (with monitoring capacity or not) is to improve HF management beyond a small niche of predominantly younger patients with access to high-cost treatments.

    Article  PubMed  Google Scholar 

  26. Tromp J, Tay WT, Ouwerkerk W, Teng TK, Yap J, MacDonald M, et al. Multimorbidity in patients with heart failure from 11 Asian regions: a prospective cohort study using the ASIAN-HF registry. PLoS Med. 2018;15(3):e1002541.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Stewart S, Carrington MJ, Marwick TH, Davidson PM, Macdonald P, Horowitz JD, et al. Impact of home versus clinic-based management of chronic heart failure: the WHICH? (Which heart failure intervention is most cost-effective & consumer friendly in reducing hospital care) multicenter, randomized trial. J Am Coll Cardiol. 2012;60(14):1239–48.

    Article  PubMed  Google Scholar 

  28. • Scuffham PA, et al. Standard vs. intensified management of heart failure to reduce healthcare costs: results of a multicentre, randomized controlled trial. Eur Heart J. 2017;38(30):2340–8. This comparative multicentre trial represents a new generation of heart failure management trials seeking to determine what components of care are most cost-effective. Ultimately, a theoretically more cost-effective means of intensifying care (involving components of BNP-monitoring, tele-management to supplement a home-based model of care) in high-risk patients was found to be no less cost-effective than standard home-based management.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Carrington MJ, Kok S, Jansen K, Stewart S. The Green, Amber, Red Delineation of Risk and Need (GARDIAN) management system: a pragmatic approach to optimizing heart health from primary prevention to chronic disease management. Eur J Cardiovasc Nurs. 2013;12(4):337–45.

    Article  PubMed  Google Scholar 

  30. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med. 1986;314(8):512–4.

    Article  CAS  PubMed  Google Scholar 

  31. Wiley JF, Chan YK, Ahamed Y, Ball J, Carrington MJ, Riegel B, et al. Multimorbidity and the risk of all-cause 30-day readmission in the setting of multidisciplinary management of chronic heart failure: a retrospective analysis of 830 hospitalized patients in Australia. J Cardiovasc Nurs. 2018;33(5):437–45.

    Article  PubMed  Google Scholar 

  32. Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ, et al. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the coordinating study evaluating outcome of advising and counseling in heart failure (COACH). Eur J Heart Fail. 2009;11(9):847–54.

    Article  PubMed  Google Scholar 

  33. Stewart S, Wiley JF, Ball J, Chan YK, Ahamed Y, Thompson DR, et al. Impact of nurse-led, multidisciplinary home-based intervention on event-free survival across the Spectrum of chronic heart disease: composite analysis of health outcomes in 1226 patients from 3 randomized trials. Circulation. 2016;133(19):1867–77.

    Article  PubMed  PubMed Central  Google Scholar 

  34. •• Wadhera RK, et al. Association of the hospital readmissions reduction program with mortality among Medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA. 2018;320(24):2542–52. This pivotal report from the USA is a timely reminder of the extensive “real world” population of heart failure patients who are invariably older and have multimorbidity. The cost-benefits of applying more invasive devices remain problematic in such a patient population. Moreover, these data highlight that hospital avoidance programs with short-term objectives (e.g. reduce 30-day readmissions) can be counter-productive and even result in harm; in this case, a strong signal of increased mortality was found.

    Article  PubMed  PubMed Central  Google Scholar 

  35. McLennan SN, Pearson SA, Cameron J, Stewart S. Prognostic importance of cognitive impairment in chronic heart failure patients: does specialist management make a difference? Eur J Heart Fail. 2006;8(5):494–501.

    Article  PubMed  Google Scholar 

  36. Ball J, Løchen ML, Carrington MJ, Wiley JF, Stewart S. Mild cognitive impairment impacts health outcomes of patients with atrial fibrillation undergoing a disease management intervention. Open Heart. 2018;5(1):e000755.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Campbell RT, Petrie MC, Jackson CE, Jhund PS, Wright A, Gardner RS, et al. Which patients with heart failure should receive specialist palliative care? Eur J Heart Fail. 2018;20(9):1338–47.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hatter Institute, University of Cape Town, Cape Town, 8001, South Africa

    Simon Stewart

Authors
  1. Simon Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simon Stewart.

Ethics declarations

Conflict of Interest

The author declares that he has no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Implementation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stewart, S. Have Traditional Heart Failure Management Programs Reached Their “Use by” Date? Time to Apply More Nuanced Care. Curr Heart Fail Rep 16, 75–80 (2019). https://doi.org/10.1007/s11897-019-00426-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-019-00426-1

Keywords

Search

Navigation